The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Enhanced Vascular Activity of Endogenous Endothelin-1 in Obese Hypertensive Patients
Abstract
Hypertensive patients have increased endothelin-1–dependent vasoconstrictor tone. This abnormality, however, might not be uniformly present in all forms of hypertension, as suggested by experimental studies showing that endothelin-1 activity is enhanced predominantly in low-renin, high-volume models and in insulin-resistant states. Because hypertension in obesity is commonly associated with both expanded plasma volume and insulin resistance, this study sought to determine whether increased body mass index (BMI) in hypertensive patients relates to activation of the endothelin-1 system. Forearm blood flow (FBF) responses (plethysmography) to intra-arterial infusion of an ET A receptor blocker (BQ-123) were analyzed in hypertensive patients and normotensive control subjects according to BMI. The vasodilator response to BQ-123 was significantly higher in hypertensive patients than in control subjects ( P <0.001). During BQ-123, a significant increase in FBF from baseline was observed in obese (BMI ≥30 kg/m 2 ; P <0.001) and overweight (BMI, 27 to 29.9 kg/m 2 ; P =0.04) but not in lean (BMI <27 kg/m 2 ; P =0.83) hypertensive patients. In contrast, no significant change in FBF was observed during BQ-123 either in obese ( P =0.53), overweight ( P =0.76), or lean ( P =0.93) normotensive subjects. Moreover, a significant correlation between BMI and the vasodilator response to ET A blockade was observed in hypertensive subjects ( R =0.53; P =0.005) but not in control subjects ( R =0.11; P =0.58). In human hypertension, increased BMI is associated with enhanced ET A -dependent vasoconstrictor activity, suggesting that this abnormality may play a role in the pathophysiology of obesity-related hypertension and that targeting the endothelin-1 system may be useful in the treatment of these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin Stimulates Both Endothelin and Nitric Oxide Activity in the Human Forearm
Cardillo, C., Nambi, S. S., Kilcoyne, C. M., Choucair, W. K., Katz, A., Quon, M. J., & Panza, J. A. (1999) · Circulation · doi:10.1161/01.cir.100.8.820 · Cited by 301
Self-citation
Cited by
Endothelial dysfunction and vascular disease - a 30th anniversary update
Vanhoutte, P. M., Shimokawa, H., Feletou, M., & Tang, E. H. C. (2017) · Acta Physiologica · doi:10.1111/apha.12646 · Cited by 937
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872
Obesity-Associated Hypertension: New Insights Into Mechanisms
Rahmouni, K., Correia, M. L. G., Haynes, W. G., & Mark, A. L. (2005) · Hypertension · doi:10.1161/01.hyp.0000151325.83008.b4 · Cited by 784
Role of insulin resistance in endothelial dysfunction
Muniyappa, R., & Sowers, J. R. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-012-9229-1 · Cited by 539
The importance of endothelin-1 for vascular dysfunction in cardiovascular disease
BOHM, F., & PERNOW, J. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.06.004 · Cited by 516
Metadata
- Authors
- Cardillo, C., Campia, U., Iantorno, M., & Panza, J. A.
- Venue
- Hypertension
- Published
- 2004-01
- Volume
- 43
- Issue
- 1
- Pages
- 36-40
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2154298792
- Cited by
- 164
- References
- 1
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enhanced Vascular Activity of Endogenous Endothelin-1 in Obese Hypertensive Patients. https://app.cochat.ai/papers/10.1161/01.hyp.0000103868.45064.81
- The paper
- Cardillo, C., Campia, U., Iantorno, M., & Panza, J. A. (2004). Enhanced Vascular Activity of Endogenous Endothelin-1 in Obese Hypertensive Patients. Hypertension. https://doi.org/10.1161/01.hyp.0000103868.45064.81
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.